Dr. Christopher Michael Andreoli, MD

Dr. Andreoli practices at Harvard Vanguard Medical Associates in Braintree, Massachusetts.

Dr. Andreoli's NPI, 1134112188, was assigned on August 24, 2005. Dr. Andreoli graduated from Boston University School Of Medicine in 2001. Dr. Andreoli's Massachusetts license number on file is 223660.

Dr. Andreoli's primary practice is Harvard Vanguard Medical Associates, at 111 Grossman Dr, Braintree, MA 02184 in Norfolk County. The practice phone is (617) 421-1000.

Dr. Andreoli's primary practice is Harvard Vanguard Medical Associates in Braintree, Massachusetts. The medical group on file is Atrius Health. Dmand AI also links Dr. Andreoli to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Andreoli practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Andreoli's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Andreoli is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Andreoli has a license on file in Massachusetts.

Dmand AI lists age-related macular degeneration, glaucoma, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion, surgical retina and vitreous procedures, visual impairment and blindness and vitreous eye degeneration among the conditions Dr. Andreoli treats.

CMS data shows 609 Medicare services from Dr. Andreoli across 4 procedure codes in 2024, for 149 Medicare patients. Medicare paid $39,844 for them. Every service was in an office.

CMS counts 149 Medicare patients who saw Dr. Andreoli in 2024. The largest group is 75 to 84, with 68 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Andreoli's median patient age at 75, with 44% women.

In 2024, Dr. Andreoli wrote 34 Medicare Part D claims for 20 patients. 68% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $986 in total drug cost. In 2022, CMS named 27 claims across 2 drugs.

Dr. Andreoli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 35 papers to Dr. Andreoli, published from 2009 to 2016. 2011 was the busiest year, with 3. The most frequent topics are Visual Acuity, Eye Injuries, Penetrating and Diabetic Retinopathy. Dr. Andreoli has published most often in Am J Ophthalmol. Dr. Andreoli's most frequent co-authors are Deeba Husain, MD, Michael Thomas Andreoli, MD and Dean Eliott, MD.

Dmand AI links Dr. Andreoli to 2 clinical trials. Conditions studied include Geographic Atrophy and Macular Degeneration.

CMS Open Payments shows 7 general payments to Dr. Andreoli from 5 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 87% of the total. Alcon Laboratories Inc paid the most, $395.

Dmand AI lists 2 awards for Dr. Andreoli, most recently CMS Stage 1 EHR in 2013.

Dr. Andreoli graduated from Boston University School Of Medicine in 2001. Dr. Andreoli is a member of AAO.

Dr. Andreoli is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.